Drug General Information
Drug ID
D0M9FC
Former ID
DNC010683
Drug Name
(R)-3-(2-naphthamido)-4-m-tolylbutanoic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530771]
Structure
Download
2D MOL

3D MOL

Formula
C22H21NO3
Canonical SMILES
CC1=CC(=CC=C1)CC(CC(=O)O)NC(=O)C2=CC3=CC=CC=C3C=C2
InChI
1S/C22H21NO3/c1-15-5-4-6-16(11-15)12-20(14-21(24)25)23-22(26)19-10-9-17-7-2-3-8-18(17)13-19/h2-11,13,20H,12,14H2,1H3,(H,23,26)(H,24,25)/t20-/m1/s1
InChIKey
LDUFWTJAUGDLSR-HXUWFJFHSA-N
PubChem Compound ID
Target and Pathway
Target(s) Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 Target Info Inhibitor [530771]
KEGG Pathway RIG-I-like receptor signaling pathway
Pathway Interaction Database p73 transcription factor network
C-MYC pathway
PDGFR-beta signaling pathway
p53 pathway
Reactome ISG15 antiviral mechanism
Negative regulators of RIG-I/MDA5 signaling
WikiPathways ISG15 antiviral mechanism
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
References
Ref 530771Bioorg Med Chem Lett. 2010 Apr 1;20(7):2210-4. Epub 2010 Feb 14.Structure-based design of novel human Pin1 inhibitors (II).
Ref 530771Bioorg Med Chem Lett. 2010 Apr 1;20(7):2210-4. Epub 2010 Feb 14.Structure-based design of novel human Pin1 inhibitors (II).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.